Jingmei Li

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Molecular differences between screen-detected and interval breast cancers are largely explained by PAM50 subtypes
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
    Clin Cancer Res . 2016
  2. doi Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 171 77, Sweden
    Int J Cancer 139:2415-25. 2016
  3. doi Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
    J Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
    Ann Oncol 26:517-22. 2015
  4. pmc Effects of childhood body size on breast cancer tumour characteristics
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 12:R23. 2010
  5. pmc Coffee consumption modifies risk of estrogen-receptor negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 13:R49. 2011
  6. pmc A genome-wide association scan on estrogen receptor-negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Breast Cancer Res 12:R93. 2010
  7. pmc Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
    Jingmei Li
    Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
    Breast Cancer Res 12:R19. 2010
  8. pmc In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women--A GWAS Study Using the iCOGS Custom Genotyping Array
    Dounya Schoormans
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
    PLoS ONE 10:e0140563. 2015
  9. doi A combined analysis of genome-wide association studies in breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 17177 Stockholm, Sweden
    Breast Cancer Res Treat 126:717-27. 2011
  10. pmc Identification of two novel mammographic density loci at 6Q25.1
    Judith S Brand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels vag 12a, 171 77, Stockholm, Sweden
    Breast Cancer Res 17:75. 2015

Detail Information

Publications20

  1. ncbi Molecular differences between screen-detected and interval breast cancers are largely explained by PAM50 subtypes
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
    Clin Cancer Res . 2016
    ..A comprehensive picture of somatic changes that drive tumors to become symptomatic in the screening interval can improve understanding of the biology underlying these aggressive tumors...
  2. doi Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 171 77, Sweden
    Int J Cancer 139:2415-25. 2016
    ..BC survivors perform poorly in HRQoL in comparison with female survivors of other cancers. Our results emphasize the importance of age- and gender-appropriate comparison groups. ..
  3. doi Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
    J Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
    Ann Oncol 26:517-22. 2015
    ..We evaluated whether this genetic risk stratification can also be applied to discriminate between screen-detected and interval cancers, which are usually associated with clinicopathological and survival differences...
  4. pmc Effects of childhood body size on breast cancer tumour characteristics
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 12:R23. 2010
    ..Although a role of childhood body size in postmenopausal breast cancer risk has been established, less is known about its influence on tumour characteristics...
  5. pmc Coffee consumption modifies risk of estrogen-receptor negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 13:R49. 2011
    ..We assessed the association between coffee consumption and postmenopausal breast cancer risk in a large population-based study (2,818 cases and 3,111 controls), overall, and stratified by ER tumour subtypes...
  6. pmc A genome-wide association scan on estrogen receptor-negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Breast Cancer Res 12:R93. 2010
    ..ER status of breast cancer is important clinically, and is used both as a prognostic indicator and treatment predictor. In this study, we focused on identifying genetic markers associated with ER-negative breast cancer risk...
  7. pmc Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
    Jingmei Li
    Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
    Breast Cancer Res 12:R19. 2010
    ..In this study, we evaluate the association between mammographic density and genetic variants of the estrogen metabolic pathway...
  8. pmc In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women--A GWAS Study Using the iCOGS Custom Genotyping Array
    Dounya Schoormans
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
    PLoS ONE 10:e0140563. 2015
    ..QoL-assessments are built on a long, empirically-based, and stringent approach. There is ample evidence that QoL is, in part, heritable. We therefore performed a GWAS relating genetic variation to QoL in healthy females...
  9. doi A combined analysis of genome-wide association studies in breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 17177 Stockholm, Sweden
    Breast Cancer Res Treat 126:717-27. 2011
    ..More effort focused in these aspects of oncology can potentially open up promising avenues for the understanding of breast cancer and its prevention...
  10. pmc Identification of two novel mammographic density loci at 6Q25.1
    Judith S Brand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels vag 12a, 171 77, Stockholm, Sweden
    Breast Cancer Res 17:75. 2015
    ..We performed a large-scale genetic association study including 8,419 women of European ancestry to identify MD loci...
  11. doi Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis
    Johanna Holm
    All authors Karolinska Institutet, Stockholm, Sweden
    J Clin Oncol 34:251-8. 2016
    ....
  12. doi Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment
    Judith S Brand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 23:1764-72. 2014
    ..We evaluated the performance of a fully automated volumetric method (Volpara)...
  13. doi Volumetric mammographic density: heritability and association with breast cancer susceptibility loci
    Judith S Brand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden JSB, KH, ME, PH, KC Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, Cambridge, UK DJT Human Genetics, Genome Institute of Singapore, Singapore, Singapore JL
    J Natl Cancer Inst 106:. 2014
    ..We studied the heritability of volumetric mammographic density ascertained by a fully-automated method and the association with breast cancer susceptibility loci...
  14. doi Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer
    Fredrik Strand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Int J Cancer 140:34-40. 2017
    ..Whether this is entirely related to a reduced mammographic detectability or to a biological phenotype promoting faster tumor growth remains to be elucidated...
  15. pmc Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer
    Abbas Cheddad
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 9:e110690. 2014
    ..We describe fully automated methods for measuring both area and volumetric mammographic density from processed images...
  16. pmc The genetic basis of quality of life in healthy Swedish women: a candidate gene approach
    Dounya Schoormans
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
    PLoS ONE 10:e0118292. 2015
    ..It is hypothesized that one may have a genetic predisposition for QoL. We therefore related 139 candidate genes, selected through a literature search, to QoL in healthy females...
  17. pmc Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer
    Jingmei Li
    Genome Institute of Singapore, Singapore
    J Clin Oncol 31:2249-56. 2013
    ..However, the extent to which change in mammographic density during adjuvant tamoxifen therapy can be used to measure response to treatment is unknown...
  18. ncbi Common diseases as determinants of menopausal age
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, Stockholm 171 77, Sweden
    Hum Reprod 31:2856-2864. 2016
    ..Can the diagnosis of common diseases before menopause influence age at natural menopause (ANM) onset?..
  19. pmc Enhancement of mammographic density measures in breast cancer risk prediction
    Abbas Cheddad
    Authors Affiliations Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 23:1314-23. 2014
    ..Mammographic density is a strong risk factor for breast cancer...
  20. pmc Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
    Hatef Darabi
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Am J Hum Genet 97:22-34. 2015
    ..Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer. ..